David Collister
turbodc.bsky.social
David Collister
@turbodc.bsky.social
Nephrologist and Assistant Professor @UofAlberta into clinical trials, precision medicine, THC, sports and lols 🇨🇦🏳️‍🌈 (he/him/his)
All we have here in Canada is low dose Testing prednisone then MMF 😔 once the proteinuria rebounds

Putting these patients in ASI trials locally too
October 29, 2025 at 4:06 AM
Do you use steroidal MRAs if you don’t have access to a finerenone or aldosterone synthase inhibitor trial?
October 25, 2025 at 9:51 PM
The percentage in the placebo arm reflects that potassium fluctuations in HD are common related to missed dialysis, diet and other factors. Other takeaway is that hyperkalemia is manageable and typically harm patients.
September 3, 2025 at 3:03 AM
I think we are all excited to see how to anti-inflammatory hypothesis pans out over the next couple of years as well
September 3, 2025 at 3:00 AM
And stayed tuned for some secondary papers in addition to the ones already published on run-in adherence assessment (study within a trial) and heart failure event definitions in dialysis RCTs (meta-epidemiological)
September 3, 2025 at 2:10 AM
Late to the party but important takeaways: large publically funded international trials are feasible in dialysis, run-ins are great, low dose spironolactone is safe and consider it’s use in HFrEF in dialysis or PD for low K+ or for volume, we don’t believe the sex subgroup analysis #NephJC
September 3, 2025 at 2:09 AM
Some really interesting stories in this one!
August 16, 2025 at 9:07 PM
We need a Canadian registry!
July 30, 2025 at 6:41 PM
Local approach in the couple of places I’ve practiced in Canada is to intensify with daily HD because of the morbidity and mortality of calciphylaxis. Does this mean you would keep on PD if adequate MBD parameters? Could this be a domain in BEAT-Calci? I doubt given lack of equipoise.
July 30, 2025 at 4:51 AM
When I order eGFR cys it’s because I think eGFR Cr is falsely high or low and I have a clinical reason for this which I already know affects prognosis (e.g. cirrhosis, malignancy, neuromuscular disease, athlete). How was this accounted for?
July 23, 2025 at 1:31 AM
Would you accept 0.3mg po every other day over prednisone for “idiopathic” pericarditis?
July 8, 2025 at 11:16 PM
Great paper! Would like to see this work also done in Alberta where I suspect MRP, remuneration model, work up and evaluation process, access to weight loss programs and navigators all play a role.
June 27, 2025 at 5:05 AM
So weird
March 27, 2025 at 3:18 AM
I used this to find my current position. Definitely worth checking out, we have some fantastic institutions in Canada.
March 17, 2025 at 4:16 AM
I think the only place that does bone biopsy in Canada is in Quebec! Wish we had it availability locally.
February 24, 2025 at 5:39 PM
What’s the eGFR? 31 is probably different than 59 for the risk of adverse events. I don’t think I would have any concerns re: bisphosphonate but would monitor PTH more closely than usual and if it drops or there is an AE consider an alternative.
February 24, 2025 at 2:47 PM
Agree with getting what you can on board ASAP
February 17, 2025 at 9:06 PM
February 9, 2025 at 7:41 AM